DK1292604T3 - 2-Aminocarbonyl-9H-purinderivater - Google Patents

2-Aminocarbonyl-9H-purinderivater

Info

Publication number: DK1292604T3
Authority: DK; Denmark
Prior art keywords: aminocarbonyl; purine derivatives; purine; derivatives
Prior art date: 2000-06-06

Application number

DK01934242T

Other languages

English (en)

Inventor

Simon John Mantell

Peter Thomas Stephenson

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-06

Filing date

2001-06-05

Publication date

2009-06-15

2000-06-06 Priority claimed from GB0014048A external-priority patent/GB0014048D0/en

2000-10-11 Priority claimed from GB0024920A external-priority patent/GB0024920D0/en

2001-06-05 Application filed by Pfizer filed Critical Pfizer

2009-06-15 Application granted granted Critical

2009-06-15 Publication of DK1292604T3 publication Critical patent/DK1292604T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Psychiatry (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Rheumatology (AREA)
Biochemistry (AREA)
Communicable Diseases (AREA)
Pregnancy & Childbirth (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)

DK01934242T 2000-06-06 2001-06-05 2-Aminocarbonyl-9H-purinderivater DK1292604T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0014048A GB0014048D0 (en)	2000-06-06	2000-06-06	Purine derivatives
GB0018246A GB0018246D0 (en)	2000-06-06	2000-07-25	Purine derivatives
GB0024920A GB0024920D0 (en)	2000-06-06	2000-10-11	Purine derivatives
PCT/IB2001/000973 WO2001094368A1 (en)	2000-06-06	2001-06-05	2-aminocarbonyl-9h-purine derivatives

Publications (1)

Publication Number	Publication Date
DK1292604T3 true DK1292604T3 (da)	2009-06-15

Family

ID=27255754

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01934242T DK1292604T3 (da)	2000-06-06	2001-06-05	2-Aminocarbonyl-9H-purinderivater

Country Status (33)

Country	Link
EP (1)	EP1292604B1 (da)
JP (2)	JP4129176B2 (da)
KR (1)	KR100484704B1 (da)
CN (1)	CN1249074C (da)
AR (1)	AR030289A1 (da)
AT (1)	ATE431356T1 (da)
AU (2)	AU2001260537B2 (da)
BG (1)	BG107216A (da)
BR (1)	BR0111263A (da)
CA (1)	CA2414018C (da)
CU (1)	CU23240B7 (da)
CZ (1)	CZ20023875A3 (da)
DE (1)	DE60138702D1 (da)
DK (1)	DK1292604T3 (da)
DZ (1)	DZ3439A1 (da)
EA (1)	EA004983B1 (da)
EE (1)	EE200200678A (da)
ES (1)	ES2324816T3 (da)
GC (1)	GC0000287A (da)
HR (1)	HRP20020960A2 (da)
HU (1)	HUP0301330A3 (da)
IL (2)	IL152783A0 (da)
IS (1)	IS6599A (da)
MA (1)	MA26910A1 (da)
MX (1)	MXPA02012033A (da)
NO (1)	NO324426B1 (da)
NZ (1)	NZ522184A (da)
OA (1)	OA12279A (da)
PA (1)	PA8518801A1 (da)
PL (1)	PL360435A1 (da)
SK (1)	SK16752002A3 (da)
TW (1)	TWI227240B (da)
WO (1)	WO2001094368A1 (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7378400B2 (en)	1999-02-01	2008-05-27	University Of Virginia Patent Foundation	Method to reduce an inflammatory response from arthritis
TWI227240B (en) *	2000-06-06	2005-02-01	Pfizer	2-aminocarbonyl-9H-purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
US20030013675A1 (en) *	2001-05-25	2003-01-16	Boehringer Ingelheim Pharma Kg	Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
WO2003029264A2 (en)	2001-10-01	2003-04-10	University Of Virginia Patent Foundation	2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
GB0129270D0 (en) *	2001-12-06	2002-01-23	Pfizer Ltd	Pharmaceutical combination
GB0129273D0 (en)	2001-12-06	2002-01-23	Pfizer Ltd	Crystalline drug form
US6974803B2 (en)	2001-12-06	2005-12-13	Pfizer Inc	Pharmaceutical combination
JP2006515829A (ja) *	2002-04-10	2006-06-08	ユニバーシティオブバージニアパテントファウンデーション	炎症性疾病の処置のための、ａ２ａアデノシン受容体アゴニストの使用
US20060178403A1 (en) *	2003-03-07	2006-08-10	Neurocrine Biosciences, Inc.	Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
US7067509B2 (en)	2003-03-07	2006-06-27	Neurocrine Biosciences, Inc.	Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
TW200519106A (en)	2003-05-02	2005-06-16	Novartis Ag	Organic compounds
ATE469157T1 (de)	2003-10-21	2010-06-15	Inspire Pharmaceuticals Inc	Tetrahydrofuroä3,4-düdioxolverbindungen und zusammensetzungen und verfahren zur inhibierung der trombozytenaggregation
US7749981B2 (en)	2003-10-21	2010-07-06	Inspire Pharmaceuticals, Inc.	Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
GB2422782A (en)	2003-10-21	2006-08-09	Inspire Pharmaceuticals Inc	Non-nucleotide compositions and method for treating pain
US7335648B2 (en)	2003-10-21	2008-02-26	Inspire Pharmaceuticals, Inc.	Non-nucleotide composition and method for inhibiting platelet aggregation
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
CN101068825B (zh)	2004-08-02	2013-05-08	弗吉尼亚大学专利基金会	具有a2a激动剂活性的具有修饰的5＇-核糖基团的2-丙炔基腺苷类似物
US7442687B2 (en)	2004-08-02	2008-10-28	The University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
WO2006028618A1 (en)	2004-08-02	2006-03-16	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
GT200500281A (es) *	2004-10-22	2006-04-24	Novartis Ag	Compuestos organicos.
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
US7932376B2 (en)	2005-05-05	2011-04-26	Inspire Pharmaceuticals, Inc.	Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
EP1957530A2 (en)	2005-10-21	2008-08-20	Novartis AG	Human antibodies against il13 and therapeutic uses
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
SI2013211T1 (sl)	2006-04-21	2012-07-31	Novartis Ag	Purinski derivati za uporabo kot agonisti receptorja adenozina A A
MX2009003185A (es)	2006-09-29	2009-04-03	Novartis Ag	Pirazolopirimidinas como inhibidores de lipido cinasa pi3k.
CN101522682A (zh)	2006-10-30	2009-09-02	诺瓦提斯公司	作为抗炎剂的杂环化合物
JP5584138B2 (ja)	2008-01-11	2014-09-03	ノバルティスアーゲー	キナーゼ阻害剤としてのピリミジン類
CN102123990B (zh) *	2008-06-19	2014-07-09	武田药品工业株式会社	杂环化合物及其用途
PL2391366T3 (pl)	2009-01-29	2013-04-30	Novartis Ag	Podstawione benzimidazole do leczenia gwiaździaków
SG175738A1 (en)	2009-05-29	2011-12-29	Pfizer Ltd	Novel glucocorticoid receptor agonists
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
EA201200260A1 (ru)	2009-08-12	2012-09-28	Новартис Аг	Гетероциклические гидразоны и их применение для лечения рака и воспаления
KR101721280B1 (ko)	2009-08-17	2017-03-29	인텔리카인, 엘엘씨	헤테로사이클릭 화합물 및 이의 용도
IN2012DN01453A (da)	2009-08-20	2015-06-05	Novartis Ag
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
EP2673277A1 (en)	2011-02-10	2013-12-18	Novartis AG	[1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase
US9127000B2 (en)	2011-02-23	2015-09-08	Intellikine, LLC.	Heterocyclic compounds and uses thereof
GEP20156285B (en)	2011-02-25	2015-05-11	Aierem Elelsi	Compounds and compositions as trk inhibitors
EP2755976B1 (en)	2011-09-15	2018-07-18	Novartis AG	6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyridines as c-met tyrosine kinase inhibitors
EP2793893A4 (en)	2011-11-23	2015-07-08	Intellikine Llc	IMPROVED TREATMENT REGIMES USING MTOR INHIBITORS
CN110507654A (zh)	2012-04-03	2019-11-29	诺华有限公司	有酪氨酸激酶抑制剂的组合产品和其应用
EP2968340A4 (en)	2013-03-15	2016-08-10	Intellikine Llc	COMBINING KINASE INHIBITORS AND USES THEREOF
WO2015084804A1 (en)	2013-12-03	2015-06-11	Novartis Ag	Combination of mdm2 inhibitor and braf inhibitor and their use
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
BR112017001695A2 (pt)	2014-07-31	2017-11-21	Novartis Ag	terapia de combinação
WO2019232403A1 (en)	2018-06-01	2019-12-05	Cornell University	Combination therapy for pi3k-associated disease or disorder
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2347512C (en) *	1998-10-16	2005-12-06	Pfizer Inc.	Adenine derivatives
GB9913932D0 (en) *	1999-06-15	1999-08-18	Pfizer Ltd	Purine derivatives
TWI227240B (en) *	2000-06-06	2005-02-01	Pfizer	2-aminocarbonyl-9H-purine derivatives

2001
- 2001-05-31 TW TW090113146A patent/TWI227240B/zh not_active IP Right Cessation
- 2001-06-04 AR ARP010102656A patent/AR030289A1/es active IP Right Grant
- 2001-06-05 AU AU2001260537A patent/AU2001260537B2/en not_active Ceased
- 2001-06-05 SK SK1675-2002A patent/SK16752002A3/sk unknown
- 2001-06-05 WO PCT/IB2001/000973 patent/WO2001094368A1/en not_active Ceased
- 2001-06-05 DK DK01934242T patent/DK1292604T3/da active
- 2001-06-05 CZ CZ20023875A patent/CZ20023875A3/cs unknown
- 2001-06-05 CA CA002414018A patent/CA2414018C/en not_active Expired - Fee Related
- 2001-06-05 AT AT01934242T patent/ATE431356T1/de not_active IP Right Cessation
- 2001-06-05 EE EEP200200678A patent/EE200200678A/xx unknown
- 2001-06-05 GC GCP20011415 patent/GC0000287A/en active
- 2001-06-05 EA EA200201179A patent/EA004983B1/ru not_active IP Right Cessation
- 2001-06-05 OA OA1200200363A patent/OA12279A/en unknown
- 2001-06-05 CN CNB018108024A patent/CN1249074C/zh not_active Expired - Fee Related
- 2001-06-05 HU HU0301330A patent/HUP0301330A3/hu unknown
- 2001-06-05 NZ NZ522184A patent/NZ522184A/en unknown
- 2001-06-05 AU AU6053701A patent/AU6053701A/xx active Pending
- 2001-06-05 ES ES01934242T patent/ES2324816T3/es not_active Expired - Lifetime
- 2001-06-05 DZ DZ013439A patent/DZ3439A1/fr active
- 2001-06-05 HR HR20020960A patent/HRP20020960A2/hr not_active Application Discontinuation
- 2001-06-05 PL PL36043501A patent/PL360435A1/xx not_active Application Discontinuation
- 2001-06-05 JP JP2002501916A patent/JP4129176B2/ja not_active Expired - Fee Related
- 2001-06-05 KR KR10-2002-7016606A patent/KR100484704B1/ko not_active Expired - Fee Related
- 2001-06-05 EP EP01934242A patent/EP1292604B1/en not_active Expired - Lifetime
- 2001-06-05 IL IL15278301A patent/IL152783A0/xx active IP Right Grant
- 2001-06-05 DE DE60138702T patent/DE60138702D1/de not_active Expired - Lifetime
- 2001-06-05 MX MXPA02012033A patent/MXPA02012033A/es active IP Right Grant
- 2001-06-05 BR BR0111263-5A patent/BR0111263A/pt not_active IP Right Cessation
- 2001-06-06 PA PA20018518801A patent/PA8518801A1/es unknown
2002
- 2002-10-23 BG BG107216A patent/BG107216A/bg unknown
- 2002-10-29 IS IS6599A patent/IS6599A/is unknown
- 2002-11-26 CU CU20020281A patent/CU23240B7/es not_active IP Right Cessation
- 2002-12-02 MA MA26930A patent/MA26910A1/fr unknown
- 2002-12-04 NO NO20025821A patent/NO324426B1/no not_active IP Right Cessation
2007
- 2007-06-21 IL IL184144A patent/IL184144A/en not_active IP Right Cessation
2008
- 2008-01-15 JP JP2008005804A patent/JP2008150383A/ja active Pending

Also Published As

Publication number	Publication date
AR030289A1 (es)	2003-08-20
EA200201179A1 (ru)	2003-04-24
KR100484704B1 (ko)	2005-04-22
IL152783A0 (en)	2003-06-24
HUP0301330A3 (en)	2005-02-28
OA12279A (en)	2003-01-01
IL184144A0 (en)	2007-10-31
CN1249074C (zh)	2006-04-05
NO20025821L (no)	2003-02-04
SK16752002A3 (sk)	2004-05-04
NO324426B1 (no)	2007-10-08
CU23240B7 (es)	2007-10-17
MXPA02012033A (es)	2003-04-25
CN1434830A (zh)	2003-08-06
JP2008150383A (ja)	2008-07-03
GC0000287A (en)	2006-11-01
AU6053701A (en)	2001-12-17
PA8518801A1 (es)	2002-09-17
JP4129176B2 (ja)	2008-08-06
TWI227240B (en)	2005-02-01
NZ522184A (en)	2004-05-28
MA26910A1 (fr)	2004-12-20
EE200200678A (et)	2004-06-15
HK1054042A1 (en)	2003-11-14
DE60138702D1 (de)	2009-06-25
KR20030032962A (ko)	2003-04-26
HK1089447A1 (zh)	2006-12-01
IS6599A (is)	2002-10-29
HUP0301330A2 (hu)	2003-08-28
EP1292604B1 (en)	2009-05-13
ES2324816T3 (es)	2009-08-17
HRP20020960A2 (en)	2005-02-28
CA2414018C (en)	2007-10-16
ATE431356T1 (de)	2009-05-15
NO20025821D0 (no)	2002-12-04
PL360435A1 (en)	2004-09-06
EA004983B1 (ru)	2004-10-28
CA2414018A1 (en)	2001-12-13
BR0111263A (pt)	2003-06-17
AU2001260537B2 (en)	2006-05-25
CZ20023875A3 (cs)	2004-02-18
BG107216A (bg)	2003-05-30
IL184144A (en)	2008-11-26
DZ3439A1 (fr)	2001-12-13
EP1292604A1 (en)	2003-03-19
JP2003535871A (ja)	2003-12-02
WO2001094368A1 (en)	2001-12-13

Publication	Publication Date	Title
DK1292604T3 (da)	2009-06-15	2-Aminocarbonyl-9H-purinderivater
ATE288437T1 (de)	2005-02-15	Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
DK1280809T3 (da)	2005-11-07	Antitumorecteinascidinderivater
ATA2932001A (de)	2004-11-15	Schneefräse
ATE298332T1 (de)	2005-07-15	Decahydro-isochinolinderivate
ATE334114T1 (de)	2006-08-15	Substituierte c-cyclohexylmethylamin-derivate
AR028336A1 (es)	2003-05-07	4-hidroxi-tetrahidropiridonas fenilsubstituidas
AR028602A1 (es)	2003-05-14	Derivados de pirrol
AR028282A1 (es)	2003-04-30	Derivados de aminofenil pirimidona
ATE282021T1 (de)	2004-11-15	Substituierte aminomethyl-phenyl- cyclohexanderivate
DK1322593T3 (da)	2004-10-11	O-substituerede-6-methyl-tramadol-derivater
PT1351959E (pt)	2005-09-30	Novos derivados de pleuromutilina
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
DK1246791T3 (da)	2005-02-14	Aminomethyl-phenyl-cyklohexanonderivater
DE50112454D1 (de)	2007-06-14	Substituierte 5-amino-1-penten-3-ol-derivate
ATE374776T1 (de)	2007-10-15	Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no)	2002-09-13	2-fenylpyran-4-on-derivater
AT500246B8 (de)	2007-02-15	Chokerring
DE10196080T1 (de)	2003-07-03	Feinstzerkleinerungsmahlmaschine
ATA11602000A (de)	2005-10-15	Sonnenstandsnachführungssystem
ATA12252000A (de)	2002-01-15	Regensinkkasten
ATA17542000A (de)	2002-08-15	Hydraulikzylinder
ATA19392000A (de)	2004-01-15	Kippflügelflugzeug
DK1246793T3 (da)	2005-02-21	Substituerede aminomethyl-phenyl-cyclohexanderivater
ATA19872000A (de)	2002-04-15	Verschlussstopfen